Delivery Order SPE2DR25D3103-SPE2DR26F9H34
- Not listed
- The Defense Logistics Agency awarded a $14,254.49 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a rheumatoid arthritis treatment administered via auto-injector. This competitively awarded, firm fixed-price delivery order was finalized on June 13, 2025, with an ultimate completion date of June 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $15,027.29 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, utilized firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,417.76 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $5,061.00 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price contract was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025, and represents a non-set-aside competitive award. The delivery order is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,159.08 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $19,280.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This non-set-aside contract was competitively awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a $16,642.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This award was made through open...
- The Defense Logistics Agency awarded a delivery order valued at $23,637.36 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. This firm fixed-price delivery order, issued on July 30, 2025, with a completion date of July 31, 2025, represents a non-competed award and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract leverages...
- The Defense Logistics Agency awarded a delivery order valued at $11,630.84 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9H34Delivery Order
The Defense Logistics Agency awarded a $11,362.68 delivery order to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. The award was issued on November 20, 2025, with an ultimate completion date of November 21, 2025, reflecting the expedited nature of pharmaceutical supply deliveries. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated substantial capability in fulfilling DLA medical supply requirements through its extensive portfolio of brand-name and generic medications, vaccines, and specialty medical devices across multiple therapeutic domains. This delivery order represents one of numerous pharmaceutical supply transactions the company executes under its DLA prime vendor agreement, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems requiring consistent access to specialty medications for treatment of conditions ranging from diabetes and neurological disorders to pain management and immunological diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 11/20/25 |